Quintiles reports quarterly earnings that top Wall Street expectations, and the business pipeline has CEO Tom Pike upbeat. "We believe we are well-positioned for the long-term with our $12.04 billion of backlog," he says.
Investors greet what on the surface appears to be good news for Triangle-based TransEnterix with a seesaw day of trading for the developer of robotic surgery technology. Does good news on FDA filing and capital funding end takeover rumors?
Shares in Heat Biologics regained some lost value Wednesday after the FDA lifted a "partial clinical hold" on a drug trial. The hold, which was announced last week, triggered a 25 percent plunge in Heat shares.
The Institute for Emerging Issues at NCSU hosted a two-day Emerging Issues Forum earlier this week to explore what technology automation and robotics means for future workers. Jim Roberts, who leads the Network for Entrepreneurs in Wilmington (NEW), found much to be positive about.
In today's Bulldog wrapup of technology news: The government redefines "driver" in a boost for computer-controlled cars; Durham-based Adwerx launches new advertising product; Twitter tweaks its timeline; and Chinese investors offer $1.2B for Norwegian tech firm Opera.
SoBran BioScience, a 500-employee contract research organization based in Fairfax, Va., will open a new animal research facility this summer in Greensboro, providing a bio-boost for the Triad.
A National Science Foundation-supported conference at NCSU over the next two days will explore the creation of a roadmap toward developing a national Internet of Things strategy. Here's a preview of what's going on.
A new research report from Juniper breaks down what its analysts view as the top disruptors in the financial technical services, or FinTech, space. Our WTW Insider subscribers get a look at the top three.
Does HQ Raleigh's Big News Involve Charlotte's Packard Place? A Charleston Campus? Similar messaging on social media by startup hubs in Raleigh and Charlotte hint at big news for the state's startup ecosystem this week.
Watson will help Moogfest attendees compose their own songs, but there will be plenty of human performers, too, at the Durham event. New additions include synth-pop band Grimes and pop trio Mike Snow.
The former CEO and CFO of Salix Pharmaceuticals, which was sold to Valeant Pharmaceuticals for more than $11 billion a year ago, are being investigated by the SEC, according to the Reuters news service.
NC IDEA will launch its next round of awarding up to $50,000 in non-dilutive grants to startups on Feb. 15. Entrepreneurs can learn more about the program at a series of state-wide meetings. and webinars.
Chimerix, which has a contract potentially worth more than $400 million in the development of a first vaccine targeting smallpox, reports progress in development of an antiviral. In recent tests, its brincidofovir successfully treated 100 percent of animals infected with rabbitpox.
Analysis: Cognizant is increasingly encroaching on IBM and Accenture's territory by building out its consulting scale and digital and cloud expertise, writes Technology Business research Analyst Jennifer Hamel. Our Insiders get the full story.
Amid the doom and gloom about a possible jobless future due to technology automation and robotics, a team of North Carolina School of Science and Mathematics - The Zebracorns - remain excited about the future.
Talk about a sell-off. Early Monday, Triangle-based Biocryst disclosed news that a drug candidate targeting a rare genetic condition had failed. The news set off an immediate plunge in its share price, triggered a Wall Street downgrade - and a possible lawsuit.
Novan Therapeutics, a high-profile emerging pharmaceutical firm backed by big-name investors in the Triangle with a focus on developing new dermatology treatments, has a new chairman. But his name is a familiar one. Another well-known name leaves the board in the shuffle.